Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer
- 15 February 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (4) , 1213-1220
Abstract
Activity of receptor tyrosine kinases (RTK) in colorectal cancer (CRC) is associated with enhanced tumor growth and a poorer prognosis. In addition, cyclooxygenase-2 (COX-2) expression contributes to tumor growth and invasion. COX-2 inhibitors exhibit important anticarcinogenic potential against CRC, but the molecular mechanism underlying this effect and the relation with RTK signaling remain the subject of intense research effort. Therefore, the rapid effects of COX-2 inhibition in CRC on the complement of all cellular kinases were investigated using a kinase substrate peptide array, Western blotting, transfection, small interfering RNA assays, and CRC cell lines. The resulting alterations in the kinome profile revealed that celecoxib, a selective COX-2 inhibitor, impairs phosphorylation of substrates for the RTKs c-Met and insulin-like growth factor receptor, resulting in decreased downstream signaling. The decrease in c-Met activation is accompanied with an increase in glycogen synthase kinase 3β kinase activity together with a rapid increase in phosphorylation of β-catenin. In agreement, a significant reduction of β-catenin-T-cell factor–dependent transcription is observed both with celecoxib and selective inhibition of c-Met phosphorylation by small molecules. Hence, corepression of c-Met–related and β-catenin–related oncogenic signal transduction seems a major effector of celecoxib in CRC, which provides a rationale to use c-Met inhibitors and celecoxib analogous to target c-Met and Wnt signaling in a therapeutic setting for patients with CRC. [Cancer Res 2008;68(4):1213–20]Keywords
This publication has 34 references indexed in Scilit:
- Evidence for a Minimal Eukaryotic Phosphoproteome?PLOS ONE, 2007
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Oncogenic K-ras Stimulates Wnt Signaling in Colon Cancer Through Inhibition of GSK-3βGastroenterology, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- In the market-placeNature, 2004
- Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer CellsJournal of Biological Chemistry, 2004
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995